{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,11,13]],"date-time":"2026-11-13T22:54:06Z","timestamp":1794610446172,"version":"4.9.1"},"reference-count":23,"publisher":"Wiley","issue":"3","license":[{"start":{"date-parts":[[2002,1,12]],"date-time":"2002-01-12T00:00:00Z","timestamp":1010793600000},"content-version":"vor","delay-in-days":225,"URL":"http:\/\/onlinelibrary.wiley.com\/termsAndConditions#vor"}],"content-domain":{"domain":["onlinelibrary.wiley.com"],"crossmark-restriction":true},"short-container-title":["Br J Haematol"],"published-print":{"date-parts":[[2001,6]]},"abstract":"<jats:p>Adult T\u2010cell leukaemia lymphoma (ATLL) is an aggressive disease caused by the human T\u2010lymphotropic virus 1 (HTLV\u2010I) with a short survival. Responses to interferon alpha (IFN\u2010\u03b1) and zidovudine (AZT) have been documented but not with long\u2010term follow\u2010up. We treated 15 ATLL patients with IFN and AZT. Eleven patients had acute ATLL, two had lymphoma and two smouldering ATLL, with progression. The main features were: organomegaly (14), skin lesions (10), high white blood cell (WBC) count (11) and hypercalcaemia (9). Eleven patients had previously received chemotherapy and one had received an autograft. At the time of the study, seven patients had progressive disease and eight were in partial or complete clinical remission. Responses (PR) lasting 2+ to 44+\u2003months were seen in 67%; 26% did not respond (NR) and one patient was not evaluable. Hypercalcaemia predicted a poor outcome but differences were not significant. Eight of the 15 patients have died 3\u201341\u2003months from diagnosis. Median survival for the 15 patients was 18\u2003months. Survival of the NR ranged from 4 to 20\u2003months; six PR patients are alive 8\u201382\u2003months from diagnosis. The differences in survival between NR (median: 6\u2003months) and PR (55% of patients alive at 4\u2003years) were statistically significant (<jats:italic>P<\/jats:italic>\u2003=\u20030\u00b7002). In conclusion, IFN and AZT improves the outcome of ATLL patients and helps maintain responses.<\/jats:p>","DOI":"10.1046\/j.1365-2141.2001.02794.x","type":"journal-article","created":{"date-parts":[[2003,3,11]],"date-time":"2003-03-11T06:34:18Z","timestamp":1047364458000},"page":"779-784","update-policy":"https:\/\/doi.org\/10.1002\/crossmark_policy","source":"Crossref","is-referenced-by-count":96,"title":["Interferon \u03b1 and zidovudine therapy in adult T\u2010cell leukaemia lymphoma: response and outcome in 15 patients"],"prefix":"10.1111","volume":"113","author":[{"given":"E.","family":"Matutes","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"G. P.","family":"Taylor","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"J.","family":"Cavenagh","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"A.","family":"Pagliuca","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"D.","family":"Bareford","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"A.","family":"Domingo","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"M.","family":"Hamblin","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"S.","family":"Kelsey","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"N.","family":"Mir","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"J. T.","family":"Reilly","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"311","published-online":{"date-parts":[[2002,1,12]]},"reference":[{"key":"e_1_2_6_2_1","doi-asserted-by":"publisher","DOI":"10.1006\/viro.1996.0101"},{"key":"e_1_2_6_3_1","doi-asserted-by":"publisher","DOI":"10.1056\/NEJM199506293322603"},{"key":"e_1_2_6_4_1","doi-asserted-by":"publisher","DOI":"10.1056\/NEJM199506293322604"},{"key":"e_1_2_6_5_1","first-page":"2975","article-title":"Clinical study on the effect of natural alpha\u2010interferon (HLBI) in the treatment of adult T\u2010cell leukemia","volume":"15","author":"Ichimaru M.","year":"1988","journal-title":"Japanese Journal of Cancer Chemotherapy"},{"key":"e_1_2_6_6_1","doi-asserted-by":"publisher","DOI":"10.1002\/1097-0142(19931215)72:12<3614::AID-CNCR2820721211>3.0.CO;2-E"},{"key":"e_1_2_6_7_1","doi-asserted-by":"publisher","DOI":"10.1111\/j.1365-2141.1994.tb05040.x"},{"key":"e_1_2_6_8_1","doi-asserted-by":"publisher","DOI":"10.1046\/j.1365-2141.2000.02033.x"},{"key":"e_1_2_6_9_1","doi-asserted-by":"publisher","DOI":"10.1136\/bmj.292.6529.1171"},{"key":"e_1_2_6_10_1","first-page":"113","volume-title":"Adult T\u2010Cell Leukaemia","author":"Matutes E.","year":"1994"},{"key":"e_1_2_6_11_1","unstructured":"Matutes E.&Catovsky D.(1998)Adult T\u2010cell leukaemia\/lymphoma. In:Leukaemia and Related Disorders 3rd edn(ed. byJ.A.Whittaker) pp.136\u2013150 Oxford."},{"key":"e_1_2_6_12_1","doi-asserted-by":"publisher","DOI":"10.1200\/JCO.1994.12.12.2588"},{"key":"e_1_2_6_13_1","doi-asserted-by":"publisher","DOI":"10.3109\/10428199809057597"},{"key":"e_1_2_6_14_1","doi-asserted-by":"publisher","DOI":"10.1002\/ijc.2910600617"},{"key":"e_1_2_6_15_1","first-page":"251","article-title":"Adult T\u2010cell leukaemia\u2010lymphoma: a clinico\u2010pathologic study of twenty six patients from Martinique","volume":"7","author":"Plumelle Y.","year":"1993","journal-title":"Hematology Pathology"},{"key":"e_1_2_6_16_1","doi-asserted-by":"publisher","DOI":"10.7326\/0003-4819-111-11-871"},{"key":"e_1_2_6_17_1","doi-asserted-by":"publisher","DOI":"10.3109\/10428199009106469"},{"key":"e_1_2_6_18_1","doi-asserted-by":"publisher","DOI":"10.1002\/ajh.2830350403"},{"key":"e_1_2_6_19_1","doi-asserted-by":"publisher","DOI":"10.1111\/j.1365-2141.1991.tb08051.x"},{"key":"e_1_2_6_20_1","doi-asserted-by":"publisher","DOI":"10.1016\/S0140-6736(83)91017-6"},{"key":"e_1_2_6_21_1","doi-asserted-by":"publisher","DOI":"10.1002\/1097-0142(19870315)59:6<1059::AID-CNCR2820590602>3.0.CO;2-M"},{"key":"e_1_2_6_22_1","first-page":"29","article-title":"Adult T\u2010cell leukaemia\/lymphoma in England 1996\u201399. High mortality, younger patients and more common than expected","volume":"108","author":"Taylor G.P.","year":"2000","journal-title":"British Journal of Haematology"},{"key":"e_1_2_6_23_1","first-page":"238","volume-title":"Adult T\u2010Cell Leukaemia","author":"Waldmann T.A.","year":"1994"},{"key":"e_1_2_6_24_1","doi-asserted-by":"crossref","first-page":"1805","DOI":"10.1182\/blood.V72.5.1805.1805","article-title":"Therapy of patients with human T\u2010cell lymphotropic virus I\u2010induced T\u2010cell leukemia with anti\u2010Tac, a monoclonal antibody to the receptor for interleukin\u20102","volume":"72","author":"Waldmann T.A.","year":"1988","journal-title":"Blood"}],"container-title":["British Journal of Haematology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.wiley.com\/onlinelibrary\/tdm\/v1\/articles\/10.1046%2Fj.1365-2141.2001.02794.x","content-type":"unspecified","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.wiley.com\/onlinelibrary\/tdm\/v1\/articles\/10.1046%2Fj.1365-2141.2001.02794.x","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/onlinelibrary.wiley.com\/doi\/pdf\/10.1046\/j.1365-2141.2001.02794.x","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2023,9,27]],"date-time":"2023-09-27T15:13:07Z","timestamp":1695827587000},"score":1,"resource":{"primary":{"URL":"https:\/\/onlinelibrary.wiley.com\/doi\/10.1046\/j.1365-2141.2001.02794.x"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2001,6]]},"references-count":23,"journal-issue":{"issue":"3","published-print":{"date-parts":[[2001,6]]}},"alternative-id":["10.1046\/j.1365-2141.2001.02794.x"],"URL":"https:\/\/doi.org\/10.1046\/j.1365-2141.2001.02794.x","archive":["Portico"],"relation":{},"ISSN":["0007-1048","1365-2141"],"issn-type":[{"value":"0007-1048","type":"print"},{"value":"1365-2141","type":"electronic"}],"subject":[],"published":{"date-parts":[[2001,6]]},"assertion":[{"value":"2002-01-12","order":2,"name":"published","label":"Published","group":{"name":"publication_history","label":"Publication History"}}]}}